WeVote
Log In

Bill

Bill

S 1418

An Act relative to fetal opioid drug exposure

194th Legislature (2025-2026) Introduced by Peter Durant and 1 co-sponsor

Massachusetts bill establishing policies to address opioid exposure in utero, currently advancing through health care financing review with impacts on maternal treatment and newborn care.

Bill reported favorably by committee and referred to the committee on Health Care Financing
0
WeVote Research Nonpartisan
Bill Summary · S 1418

Legislative bill overview

S 1418 addresses fetal opioid drug exposure by establishing policies, programs, or requirements related to maternal opioid use and its effects on newborns. The bill has progressed through committee review and is currently in the Health Care Financing committee stage. The specific provisions are not detailed in the available action history.

Why is this important

Prenatal opioid exposure affects thousands of infants annually, resulting in neonatal abstinence syndrome (NAS) and long-term developmental concerns. Massachusetts, like other states, faces increasing rates of opioid-exposed births, making legislative responses relevant to healthcare costs, child welfare systems, and treatment availability for pregnant individuals with opioid use disorder.

Potential points of contention

  • Treatment access vs. criminalization: Whether the bill incentivizes treatment for pregnant individuals or creates barriers through mandatory reporting or legal consequences
  • Healthcare costs and coverage: Questions about who bears financial responsibility for specialized care, monitoring, and treatment services for affected mothers and infants
  • Parental rights and child welfare: Concerns about how exposure is documented and whether it triggers automatic involvement of child protective services or affects parental custody

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.